Health professional information [1]
Version 3 Criteria coming soon!
The Criteria for Immunoglobulin Use in Australia (the Criteria) is changing to Version 3 from 22 October 2018.
The Criteria will be released electronically within BloodSTAR [2] and will also be available at criteria.blood.gov.au [3]. A printed version will no longer be available. From October 22 information for each medical condition can be printed from BloodSTAR [2] or criteria.blood.gov.au [3] if required, but any printed version must regularly be checked for currency.
Summary of medical condition changes by specialty for Health Professionals
- Haematology conditions summary of changes [4] (3.9 MB)
- Immunology condition summary of changes [5] (3.96 MB)
- Neurology conditions summary of changes [6] (4.02 MB)
- Transplantation conditions summary of changes [8] (2.89 MB)
Conditions as they appear in the Criteria
Haematology conditions |
Immunology condition |
Neurology conditions |
Transplantation conditions |
Acquired hypogammaglobulinaemia secondary to haematological malignancies, or post-haemopoietic stem cell transplantation (HSCT) |
Anti-neutrophil cytoplasmic antibody (ANCA) [Proteinase 3 (PR3) or myeloperoxidase (MPO)] - positive systemic necrotising vasculitis |
Acute disseminated encephalomyelitis (ADEM) |
Solid organ transplantation |
Autoimmune haemolytic anaemia (AIHA) |
Autoimmune congenital heart block |
Autoimmune encephalitis mediated by antibodies targeting cell-surface antigens (AMAE) |
|
Autoimmune neutropenia |
Autoimmune retinopathy (AIR) |
Childhood epileptic encephalopathy |
|
Fetal and neonatal alloimmune thrombocytopenia (FNAIT) |
Bullous pemphigoid (BP) |
Chronic inflammatory demyelinating polyneuropathy (CIDP), (including IgG and IgA paraproteinaemic demyelinating neuropathies) |
|
Haemolytic disease of the fetus (HDF) |
Catastrophic anti-phospholipid syndrome (CAPS) |
Guillain–Barré Syndrome including variants (GBS) |
|
Haemolytic transfusion reaction (hyperhaemolysis syndrome)
|
Cicatricial pemphigoid (CP) or Mucous Membrane Pemphigoid (MMP) |
IgM paraproteinaemic demyelinating neuropathy |
|
Immune thrombocytopenic purpura (ITP) — adult |
Epidermolysis bullosa acquisita |
Inflammatory Myopathies: Inclusion Body Myositis (IBM) |
|
Immune thrombocytopenic purpura (ITP) — in children 15 years and younger |
Graves ophthalmopathy |
Inflammatory myopathies: polymyositis (PM), dermatomyositis (DM) and necrotising autoimmune myopathy (NAM) |
|
Neonatal haemochromatosis (NH) |
Kawasaki disease (mucocutaneous lymph node syndrome) |
Lambert–Eaton myasthenic syndrome (LEMS) |
|
Post-transfusion purpura (PTP) |
Pemphigus foliaceus (PF) |
Multifocal motor neuropathy (MMN) |
|
Pure red cell aplasia (PRCA) |
Pemphigus vulgaris (PV) |
Multiple sclerosis - (MS) [relapsing remitting multiple sclerosis (RRMS)] |
|
Haemophagocytic lymphohistiocytosis (HLH) |
Primary immunodeficiency diseases (PID) with antibody deficiency |
Myasthenia gravis (MG) |
|
Acquired haemophilia and congenital haemophilia with inhibitors (Coagulation factor inhibitors) |
Pyoderma Gangrenosum (PG) |
Neuromyelitis optica spectrum disorders (NMOSD) |
|
|
Scleromyxedema |
Opsoclonus-myoclonus ataxia (OMA) |
|
|
Secondary hypogammaglobulinaemia unrelated to Haematological malignancy or haemopoeitic stem cell transplant (HSCT) |
Paediatric autoimmune neuropsychiatric disorder associated with streptococcal infections (PANDAS) or paediatric acute neuropsychiatric disorders (PANS) |
|
|
Specific antibody deficiency |
Rasmussen encephalitis |
|
|
Systemic capillary leak syndrome |
Sjögren’s syndrome associated neuropathy |
|
|
Toxic epidermal necrolysis (TEN; Lyell syndrome) / Stevens–Johnson syndrome (SJS) |
Stiff person syndrome |
|
|
Toxic shock syndrome (TSS) |
Susac syndrome |
|
Other conditions
No longer supported conditions |
Diabetic amyotrophy Factsheet [113] (1.27 MB) |
HIV in children Factsheet [114] (1.26 MB) |
Myocarditis in children Factsheet [115] (1.26 MB) |
Paraneoplastic neurological syndromes - cerebellar degeneration Factsheet [116] (1.27 MB) |
Paraneoplastic neurological syndromes - subacute sensory neuropathy Factsheet [116] (1.27 MB) |
Pure white cell aplasia (PWCA) Factsheet [117] (1.27 MB) |
No longer stand-alone conditions | May now apply using |
Acute leukaemia |
Acquired hypogammaglobulinaemia secondary to haematological malignancies, or post-haemopoietic stem cell transplantation [HSCT] Factsheet [10] (1.41 MB) |
Evans syndrome or Autoimmune haemolytic anaemia with immune thrombocytopenia (AIHA with ITP) |
Autoimmune haemolytic anaemia [AIHA] Factsheet [18] (1.41 MB) Immune thrombocytopenic purpura [ITP] – adult Factsheet [48] (1.41 MB) Immune thrombocytopenic purpura [ITP] – in children 15 years and younger Factsheet [54] (1.41 MB) |
Hashimoto encephalopathy (steroid-responsive encephalopathy associated with autoimmune thyroiditis) |
Autoimmune encephalitis mediated by antibodies targeting cell-surface antigens [AMAE] Factsheet [22] (1.41 MB) |
Kidney transplantation |
Solid organ transplantation Factsheet [16] (1.42 MB) |
Limbic encephalitis – nonparaneoplastic |
Autoimmune encephalitis mediated by antibodies targeting cell-surface antigens [AMAE] Factsheet [22] (1.41 MB) |
Paraneoplastic neurological syndromes - limbic encephalitis |
Autoimmune encephalitis mediated by antibodies targeting cell-surface antigens [AMAE] Factsheet [22] (1.41 MB) |
Potassium channel antibody-associated encephalopathy |
Autoimmune encephalitis mediated by antibodies targeting cell-surface antigens [AMAE] Factsheet [22] (1.41 MB) |
Solid organ transplantation (other than kidney) |
Solid organ transplantation Factsheet [16] (1.42 MB) |